Subscribe Become an Author Add Company Sign Up Log In

TwoXAR

TwoXAR

Private company
TWOXAR

The convergence of big data, cloud computing, and artificial intelligence has allowed twoXAR to build a drug discovery platform that is order of magnitudes faster, cheaper, and more accurate than traditional wet-lab based approaches.

twoXAR leverages its technology internally to build its own pipeline of therapeutic candidates across diseases as well as collaborate with biotechnology and pharmaceutical companies to jointly discover and develop novel drug candidates by:

- Screening compound libraries for efficacy against a disease or list of diseases
- Screening compound libraries for efficacy against a disease or list of diseases
- Identifying biologic targets from the elucidation of novel biology


Founded
2014
Status
Private company
Geography
United States of America based
Funding
$14.300 M
Research papers
3
Business model
  • Operations Service
Therapeutic focus
  • Dermatology
Research focus
  • Biology research (Target identification/validation)

Investing history

2018Series A10.0
2015Seed round0.9
2015Seed round3.4

Press releases

    No mentions found

Posts Mentioning This Company

Biopharma Insights

Products

No products posted yet

Services

No services posted yet

Clinical Trials

    No clinical trials found

Patents/applications

    No patents found

Publications (PubMed)
  • 31988426 (from 2020-01-29), Author Correction: Multi-omics analysis of multiple missions to space reveal a theme of lipid dysregulation in mouse liver.
  • 31844325 (from 2019-12-18), Multi-omics analysis of multiple missions to space reveal a theme of lipid dysregulation in mouse liver.
  • 27940607 (from 2016-12-13), Synergistic drug combinations from electronic health records and gene expression.

Assets (therapeutic products)

    No assets found

Year Partner Focus Amount of Deal
2017

(2017, Jan. 1)
Santen Pharmaceuticals -- --